Cargando…
Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report
RATIONALE: The diagnosis of anaplastic lymphoma kinase (ALK)-negative inflammatory myofibroblastic tumors (IMT) remains challenging because of their morphological resemblance with spindle cell sarcoma with myofibroblastic characteristics. PATIENT CONCERNS: A 69-year-old female patient presented with...
Autores principales: | Hou, Tien-Chi, Wu, Pao-Shu, Huang, Wen-Yu, Yang, Yi-Ting, Tan, Kien Thiam, Liu, Shih-Hua, Chen, Yu-Jen, Chen, Shu-Jen, Su, Ying-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220190/ https://www.ncbi.nlm.nih.gov/pubmed/32195970 http://dx.doi.org/10.1097/MD.0000000000019577 |
Ejemplares similares
-
A rare double ALK fusion variant EML4-ALK and CDK15-ALK in lung adenocarcinoma and response to crizotinib: A case report
por: Guo, Jun, et al.
Publicado: (2020) -
ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations
por: Debonis, Silvia Angela, et al.
Publicado: (2021) -
A case report of recurrent thyroid inflammatory myofibroblastic tumor and its metastasis in soft tissue
por: Duan, Jiajia, et al.
Publicado: (2017) -
Racial patterns of patients with primary mediastinal large B-cell lymphoma: SEER analysis
por: Liu, Pan-Pan, et al.
Publicado: (2016) -
Identification of triple gene fusion ALK-LRRN2, LTBP1-ALK, and HIP1-ALK in advanced lung adenocarcinoma and response to alectinib: A case report
por: Ning, Shangkun, et al.
Publicado: (2021)